期刊文献+

腔隙性脑梗死患者FXII CRM^+及其对纤溶酶原活性影响的初步研究 被引量:3

The change of FXII CRM^+ and initial study of its effect on profilorinolysin in cerebral infarction patient
下载PDF
导出
摘要 目的 :研究接触启动系统的凝血因子 XII(FXII)在激活纤溶酶和血管病变时对纤溶酶原活性的影响。方法 :分别检测 80例腔隙性脑梗死 (简称腔梗 )患者和 5 9例正常对照者的血浆 PL G:A、α2 AP:A、D-二聚体、FXI-I:Ag和 F1 + 2 水平 ,并比较两组各项指标的差异 ,以了解腔梗患者的纤溶酶原活性及潜在的纤溶酶原功能在血管病变中的作用。结果 :2 8例腔梗患者存在明显的 FXII:C减低 ,和 α2 AP:A升高 ,而 PL G:A、FXII:Ag和 D-二聚体水平与正常对照组差异无显著性意义 (P >0 .0 5 ) ,而血浆 F1 + 2 水平均增高。结论 :部分腔梗患者存在 FXII CRM+可能是引起血栓形成的重要因素 ,并有必要对 FXII基因的多态性作进一步研究。 Objective:To study contact system factor XII activated plasminogen and affected on fibrinolysis when associated vascular disease was present.Method:PLG:A, α 2AP:A,D-Dimer,F 1+2 ,FXII:C and FXII:Ag were determinated in 80 lacunar infarction patients and 59 health controls.The difference was compared between the patients and controls to investigate activity.Result:There is significant decrease in FXII:C and increase in α 2AP:A and plasma F 1+2 level in 28 patients with lacunar infarction. No change of PLG:A,plasma XII:Ag and D-Dimer level the patients and controls.Conclusion:There is a change of FXII CRM+ in lacunar infarction patients.which may be an important factor in inducily thrombosis in hypercoagulant state.It is suggested that further study of FXII gene polymorphism is necessary.
出处 《临床血液学杂志》 CAS 2000年第5期201-203,共3页 Journal of Clinical Hematology
关键词 腔隙性脑梗死 凝血因子XⅡ 纤溶酶原 Lacunar infarction FactorXII Fibrinolysis
  • 相关文献

同被引文献23

  • 1王运良,刘滨,刘萍,耿爽,石传江,熊晖.腔隙性脑梗死患者血压变化与预后的关系分析[J].山东医药,2005,45(1):8-9. 被引量:1
  • 2张允岭,韩振蕴,金香兰,王玉来.对中医药治疗腔隙性脑梗死重要性的认识[J].北京中医药大学学报,2005,28(4):72-73. 被引量:3
  • 3石玉如,张允岭,戴中,张綦慧,柳洪胜,扈新刚,金香兰.腔隙性脑梗死认知缺损证候学观察与分析[J].北京中医药大学学报,2006,29(5):350-354. 被引量:13
  • 4Michael L,Murat T,John K,et al.Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age[J].Ophthalmology,2002,109:126-131.
  • 5Prisco D,Marcucci R.Retinal vein thrombosis:risk factors,pathogenesis and therapeutic approach[J].Pathophysiol Haemost Thromb,2002,32(5-6):308-311.
  • 6Prisco D,Marcucci R,Bertini L,et al.Cardiovascular and thrombophilic risk factors for central retinal vein occlusion[J].Eur J Intern Med,2002,13(3):163-169.
  • 7Lahey JM,Kearney JJ,Tunc M.Hypercoagulable states and central retinal vein occlusion[J].Curr Opin Pulm Med,2003,9(5):385-392.
  • 8van Cott EM,Laposata M,Hartnett ME.Prothrombin gene mutation G20210A,homocysteine,antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis[J].Blood Coagul Fibrinolysis,2004,15(5):393-397.
  • 9Speicher L,Philipp W,Kunz FJ.Factor Ⅻ deficiency and central retinal vein occlusion[J].Lancet,1992,340(8813):237.
  • 10Abu El-Asrar AM,Abdel Gader AG,Al-Amro S,et al.Hypercoagulable states in patients with retinal venous occlusion[J].Doc Ophthalmol,1998,95(2):133-143.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部